Trade INC Research - SYNH CFD
Add to favourite- Summary
- Historical Data
Spread | 0.09 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 42.93 |
Open | 42.93 |
1-Year Change | -9.92% |
Day's Range | 42.93 - 42.94 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Sep 27, 2023 | 42.93 | 0.00 | 0.00% | 42.93 | 42.94 | 42.93 |
Sep 26, 2023 | 42.93 | 0.22 | 0.52% | 42.71 | 42.94 | 42.70 |
Sep 25, 2023 | 42.73 | 0.04 | 0.09% | 42.69 | 42.75 | 42.69 |
Sep 22, 2023 | 42.68 | -0.08 | -0.19% | 42.76 | 42.77 | 42.68 |
Sep 21, 2023 | 42.73 | -0.01 | -0.02% | 42.74 | 42.74 | 42.71 |
Sep 20, 2023 | 42.75 | -0.04 | -0.09% | 42.79 | 42.80 | 42.74 |
Sep 19, 2023 | 42.78 | 0.05 | 0.12% | 42.73 | 42.78 | 42.73 |
Sep 18, 2023 | 42.74 | 0.03 | 0.07% | 42.71 | 42.74 | 42.71 |
Sep 15, 2023 | 42.70 | -0.03 | -0.07% | 42.73 | 42.78 | 42.70 |
Sep 14, 2023 | 42.73 | 0.01 | 0.02% | 42.72 | 42.78 | 42.71 |
Sep 13, 2023 | 42.73 | 0.03 | 0.07% | 42.70 | 42.76 | 42.70 |
Sep 12, 2023 | 42.70 | -0.02 | -0.05% | 42.72 | 42.74 | 42.70 |
Sep 11, 2023 | 42.72 | 0.07 | 0.16% | 42.65 | 42.72 | 42.65 |
Sep 8, 2023 | 42.66 | -0.02 | -0.05% | 42.68 | 42.71 | 42.66 |
Sep 7, 2023 | 42.69 | -0.02 | -0.05% | 42.71 | 42.73 | 42.69 |
Sep 6, 2023 | 42.72 | 0.02 | 0.05% | 42.70 | 42.80 | 42.69 |
Sep 5, 2023 | 42.68 | -0.01 | -0.02% | 42.69 | 42.70 | 42.56 |
Sep 1, 2023 | 42.66 | 0.08 | 0.19% | 42.58 | 42.69 | 42.58 |
Aug 31, 2023 | 42.68 | 0.04 | 0.09% | 42.64 | 42.68 | 42.61 |
Aug 30, 2023 | 42.64 | 0.08 | 0.19% | 42.56 | 42.65 | 42.55 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
INC Research Company profile
About Syneos Health Inc
Syneos Health, Inc. is a biopharmaceutical solutions company. It provides a range of clinical and commercial services to customers in the pharmaceutical, biotechnology, and healthcare industries. It offers both stand-alone and integrated biopharmaceutical product development solutions ranging from Early Phase (Phase I) clinical trials to the full commercialization of biopharmaceutical products. It operates through two business segments: Clinical Solutions and Commercial Solutions. Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. The segment offers individual services including product development, project management, protocol development, investigational site recruitment, and clinical monitoring. The Commercial Solutions segment provides commercialization services, including deployment solutions, communication solutions, and consulting services.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Syneos Health Inc revenues increased 18% to $5.21B. Net income increased 22% to $234.8M. Revenues reflect Clinical Solutions segment increase of 21% to $4.01B, Commercial Solutions segment increase of 9% to $1.2B, North America segment increase of 13% to $3.14B, Europe, Middle East and Africa segment increase of 26% to $1.33B, Asia-Pacific segment increase of 28% to $594.2M.
Industry: | Biotechnology & Medical Research (NEC) |
1030 Sync Street
MORRISVILLE
NORTH CAROLINA 27560
US
News
![](https://img.capital.com/imgs/articles/192x130x1/Risk-Management-in-Trading.png)
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ECB_0.png)
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024![](https://img.capital.com/imgs/articles/192x130x1/risk_2_1_optimized_450_1.png)
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024![](https://img.capital.com/imgs/articles/192x130x1/Stock-1-_1.png)
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ETF-1-_0.png)
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024![Lloyds share price forecast: An attractive dividend stock? Lloyds share price forecast: An attractive dividend stock?](https://img.capital.com/imgs/articles/192x130x1/shutterstock_536730610_0.jpg)
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024![](https://img.capital.com/imgs/articles/192x130x1/RBNZ.png)
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com